Outpatient monitoring of patients with type 2 diabetes by a primary care physician. Guidelines
Open Access
- 28 July 2025
- journal article
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 2 (2) , 98-134
Abstract
The guidelines outline modern approaches to the diagnosis and treatment of type 2 diabetes, including clinical and paraclinical methods necessary for effective monitoring of patients’ condition. Key attention is paid to outpatient follow-up. Both drug and non-drug treatment methods are presented, aimed at preventing the progression of diabetes, reducing the risk of complications and improving the quality and duration of life of patients. Algorithmization and structuring of modern clinical guidelines and standards in terms of outpatient follow-up make the document relevant, practice-o riented and useful for health professionals. The inclusion of evidence data ensures the high efficiency of the proposed approaches and their application in routine health practice.The guidelines are intended for district internists, general practitioners (family doctors), district internists of the shop medical district, as well as for secondary medical personnel working with these doctors, for paramedics of paramedic- obstetric stations (paramedic health centers) in case they are assigned the functions of the attending physician.The guidelines can be used by public health physicians, heads of primary health care facilities and their divisions.Keywords
This publication has 13 references indexed in Scilit:
- Correction to: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)European Heart Journal, 2024
- Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-dependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the framework of preventive counseling. Methodological GuidelinesCardiovascular Therapy and Prevention, 2021
- Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION studyDiabetes mellitus, 2020
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetesDiabetes & Vascular Disease Research, 2019
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)Diabetes mellitus, 2016
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998